Evaluation of a rotational asymmetric multifocal intraocular lens with a standard toricity and a +1.5 D near addition

Session Details

Session Title: Pseudophakic IOLs: Multifocal II

Session Date/Time: Tuesday 13/09/2016 | 08:00-10:30

Paper Time: 09:36

Venue: Auditorium C6

First Author: : F.Kretz GERMANY

Co Author(s): :    H. Kaymak   R. Gerl   M. Mueller   G. Auffarth   M. Gerl   D. Breyer     

Abstract Details

Purpose:

Clinical evaluation of a rotational-asymmetric multifocal intraocular lens with a standard toricity and a +1.5 D near addition for the correction of presbyopia and astigmatism during cataract surgery.

Setting:

multi center study of the International Vision Correction Research Centre Network (IVCRC.net), Univ. of Heidelberg, Germany

Methods:

In a prospective multicenter study patients patients that underwent cataract surgery with a corneal astigmatism ≥ 0.75 D receives a rotational-asymmetric multifocal intraocular lens with a standard toricity and a +1.5 D near addition (LS-313MF15 T1-T6, Oculentis, Germany). The preoperative biometry was performed with the IOL-Master 700 (Carl Zeiss Meditech, Germany). Subjective refraction, corrected and uncorrected visual acuity, monocular and binocular [decimal] for distance, intermediate and near as well as binocular defocus curve analysis and rotational stability were evaluated.

Results:

A significant reduction of astigmatism from -1.36 D to -0,25 D could be found. The mean postoperative monocular UDVA was 1.06, the UIVA was 1.02 and the UNVA was 0.51, respectively. Mean IOL rotation was 1.6°.

Conclusions:

Rotational-asymmetric multifocal intraocular lenses with a standard toricity and a +1.5 D near addition based on a plate haptic design show an excellent rotational stability and sufficient astigmatism correction even for small grades of astigmatism. The evaluated +1.5 D near addition MIOL shows his benefits for distance and intermediate visual acuity while still offering acceptable near visual acuity.

Financial Disclosure:

... receives consulting fees, retainer, or contract payments from a company producing, developing or supplying the product or procedure presented, ... travel has been funded, fully or partially, by a competing company, ... travel has been funded, fully or partially, by a company producing, developing or supplying the product or procedure presented, ... research is funded, fully or partially, by a competing company, ... research is funded, fully or partially, by a company producing, developing or supplying the product or procedure presented, ... receives consulting fees, retainer, or contract payments from a competing company